Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma

Pp125FAK, a protein tyrosine kinase (PTK) co‐localized with integrins in focal adhesion plaques, is known to transduce signals involved in the regulation of cell adhesion and motility as well as the anchorage‐independent growth of transformed cells. We investigated whether pp125FAK could be part of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of cancer 1996-10, Vol.68 (2), p.164-171
Hauptverfasser: Tremblay, Lise, Hauck, Wendy, Aprikian, Armen G., Begin, Louis R., Chapdelaine, Alcide, Chevalier, Simone
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 171
container_issue 2
container_start_page 164
container_title International journal of cancer
container_volume 68
creator Tremblay, Lise
Hauck, Wendy
Aprikian, Armen G.
Begin, Louis R.
Chapdelaine, Alcide
Chevalier, Simone
description Pp125FAK, a protein tyrosine kinase (PTK) co‐localized with integrins in focal adhesion plaques, is known to transduce signals involved in the regulation of cell adhesion and motility as well as the anchorage‐independent growth of transformed cells. We investigated whether pp125FAK could be part of a signalling pathway that contributes to the progression of human prostate carcinoma (PCa). Up‐regulation of pp125FAK expression, its activation by phosphorylation on tyrosine and its association with paxillin and p50csk were preferentially observed in PCa tissues from patients with metastases, whereas normal and hyperplastic prostates and localized PCa tissues showed undetectable or low levels of both FAK mRNA and protein and an absence of pp125FAK signalling complexes. The increase in expression and activation of pp125FAK in metastatic PCa tissues was also corroborated by our findings in human PCa cell lines. Indeed, higher levels of pp125FAK and FAK mRNA were observed in highly tumorigenic PC‐3 cells as was the presence of activated pp125FAK, as opposed to an inactive form in LNCaP cells, which have a lower tumorigenic ability. In addition, pp125FAK formed signalling complexes with both paxillin and p50csk in PC‐3 cells as in metastatic PCa tissues. Together, our results show that an increase in FAK mRNA and protein, as well as pp125FAK activation and association with signalling proteins, correlates with progression and invasion in human PCa tissues and cells. © 1996 Wiley‐Liss, Inc.
doi_str_mv 10.1002/(SICI)1097-0215(19961009)68:2<169::AID-IJC4>3.0.CO;2-W
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78497118</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78497118</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3184-d43264fad21b7bf997fe4f51a2fd8b5d7a0992e62ce120f9b2445f013e2db6693</originalsourceid><addsrcrecordid>eNqFkUtvEzEUhS1EVULLT0DyAqFE6gTb43k4oErRQGBopSwKdGnd8diKYV6MJ338Av42niaEBZVY2dfn-OjofgidUzKnhLA306s8y2eUiCQgjEZTKkTsBTGL0wV7R2OxWCzz90H-OePn4ZzMs_VbFlw_QZPDl6do4oNIkNAwfoaeO_edEEojwo_RcSoI4YxN0K9Vq6DCUG60s22Df9gGnMbTrqMsWi0vZljfdb12o3iGQQ32BobRCE2JwblW2d18a4cN7uDOVpXdqV1EsqsL7KfNtoYG13oAN3i3wl3fjjeNFfTKNm0Np-jIQOX0i_15gr6uPnzJPgWX6495trwMVEhTHpQ8ZDE3UDJaJIURIjGam4gCM2VaRGUCRAimY6Y0ZcSIgnEeGUJDzcoijkV4gl7vcn2Fn1vtBllbp3RVQaPbrZNJykVCaeqN33ZG5bu6XhvZ9baG_l5SIkdCUo6E5LhuOa5b_iEk41Qy6QlJ6QnJkZAMJZHZ2j9f--CX-wbbotblIXaPxOuv9jo4j8b00CjrDjbGkyRl_G-_W1vp-3_K_bfbI9Ue5vA35YK5Hw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78497118</pqid></control><display><type>article</type><title>Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via Wiley Online Library</source><creator>Tremblay, Lise ; Hauck, Wendy ; Aprikian, Armen G. ; Begin, Louis R. ; Chapdelaine, Alcide ; Chevalier, Simone</creator><creatorcontrib>Tremblay, Lise ; Hauck, Wendy ; Aprikian, Armen G. ; Begin, Louis R. ; Chapdelaine, Alcide ; Chevalier, Simone</creatorcontrib><description>Pp125FAK, a protein tyrosine kinase (PTK) co‐localized with integrins in focal adhesion plaques, is known to transduce signals involved in the regulation of cell adhesion and motility as well as the anchorage‐independent growth of transformed cells. We investigated whether pp125FAK could be part of a signalling pathway that contributes to the progression of human prostate carcinoma (PCa). Up‐regulation of pp125FAK expression, its activation by phosphorylation on tyrosine and its association with paxillin and p50csk were preferentially observed in PCa tissues from patients with metastases, whereas normal and hyperplastic prostates and localized PCa tissues showed undetectable or low levels of both FAK mRNA and protein and an absence of pp125FAK signalling complexes. The increase in expression and activation of pp125FAK in metastatic PCa tissues was also corroborated by our findings in human PCa cell lines. Indeed, higher levels of pp125FAK and FAK mRNA were observed in highly tumorigenic PC‐3 cells as was the presence of activated pp125FAK, as opposed to an inactive form in LNCaP cells, which have a lower tumorigenic ability. In addition, pp125FAK formed signalling complexes with both paxillin and p50csk in PC‐3 cells as in metastatic PCa tissues. Together, our results show that an increase in FAK mRNA and protein, as well as pp125FAK activation and association with signalling proteins, correlates with progression and invasion in human PCa tissues and cells. © 1996 Wiley‐Liss, Inc.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/(SICI)1097-0215(19961009)68:2&lt;169::AID-IJC4&gt;3.0.CO;2-W</identifier><identifier>PMID: 8900422</identifier><identifier>CODEN: IJCNAW</identifier><language>eng</language><publisher>New York: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Biological and medical sciences ; Cell Adhesion Molecules - metabolism ; Cytoskeletal Proteins - metabolism ; Focal Adhesion Kinase 1 ; Focal Adhesion Protein-Tyrosine Kinases ; Humans ; Male ; Medical sciences ; Neoplasm Proteins - metabolism ; Nephrology. Urinary tract diseases ; Paxillin ; Phosphoproteins - metabolism ; Phosphorylation ; Prostatic Neoplasms - metabolism ; Protein-Tyrosine Kinases - metabolism ; src Homology Domains ; src-Family Kinases - metabolism ; Tumor Cells, Cultured ; Tumors of the urinary system ; Urinary tract. Prostate gland</subject><ispartof>International journal of cancer, 1996-10, Vol.68 (2), p.164-171</ispartof><rights>Copyright © 1996 Wiley‐Liss, Inc.</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3184-d43264fad21b7bf997fe4f51a2fd8b5d7a0992e62ce120f9b2445f013e2db6693</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2F%28SICI%291097-0215%2819961009%2968%3A2%3C169%3A%3AAID-IJC4%3E3.0.CO%3B2-W$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2F%28SICI%291097-0215%2819961009%2968%3A2%3C169%3A%3AAID-IJC4%3E3.0.CO%3B2-W$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2477824$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8900422$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tremblay, Lise</creatorcontrib><creatorcontrib>Hauck, Wendy</creatorcontrib><creatorcontrib>Aprikian, Armen G.</creatorcontrib><creatorcontrib>Begin, Louis R.</creatorcontrib><creatorcontrib>Chapdelaine, Alcide</creatorcontrib><creatorcontrib>Chevalier, Simone</creatorcontrib><title>Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Pp125FAK, a protein tyrosine kinase (PTK) co‐localized with integrins in focal adhesion plaques, is known to transduce signals involved in the regulation of cell adhesion and motility as well as the anchorage‐independent growth of transformed cells. We investigated whether pp125FAK could be part of a signalling pathway that contributes to the progression of human prostate carcinoma (PCa). Up‐regulation of pp125FAK expression, its activation by phosphorylation on tyrosine and its association with paxillin and p50csk were preferentially observed in PCa tissues from patients with metastases, whereas normal and hyperplastic prostates and localized PCa tissues showed undetectable or low levels of both FAK mRNA and protein and an absence of pp125FAK signalling complexes. The increase in expression and activation of pp125FAK in metastatic PCa tissues was also corroborated by our findings in human PCa cell lines. Indeed, higher levels of pp125FAK and FAK mRNA were observed in highly tumorigenic PC‐3 cells as was the presence of activated pp125FAK, as opposed to an inactive form in LNCaP cells, which have a lower tumorigenic ability. In addition, pp125FAK formed signalling complexes with both paxillin and p50csk in PC‐3 cells as in metastatic PCa tissues. Together, our results show that an increase in FAK mRNA and protein, as well as pp125FAK activation and association with signalling proteins, correlates with progression and invasion in human PCa tissues and cells. © 1996 Wiley‐Liss, Inc.</description><subject>Biological and medical sciences</subject><subject>Cell Adhesion Molecules - metabolism</subject><subject>Cytoskeletal Proteins - metabolism</subject><subject>Focal Adhesion Kinase 1</subject><subject>Focal Adhesion Protein-Tyrosine Kinases</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Neoplasm Proteins - metabolism</subject><subject>Nephrology. Urinary tract diseases</subject><subject>Paxillin</subject><subject>Phosphoproteins - metabolism</subject><subject>Phosphorylation</subject><subject>Prostatic Neoplasms - metabolism</subject><subject>Protein-Tyrosine Kinases - metabolism</subject><subject>src Homology Domains</subject><subject>src-Family Kinases - metabolism</subject><subject>Tumor Cells, Cultured</subject><subject>Tumors of the urinary system</subject><subject>Urinary tract. Prostate gland</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkUtvEzEUhS1EVULLT0DyAqFE6gTb43k4oErRQGBopSwKdGnd8diKYV6MJ338Av42niaEBZVY2dfn-OjofgidUzKnhLA306s8y2eUiCQgjEZTKkTsBTGL0wV7R2OxWCzz90H-OePn4ZzMs_VbFlw_QZPDl6do4oNIkNAwfoaeO_edEEojwo_RcSoI4YxN0K9Vq6DCUG60s22Df9gGnMbTrqMsWi0vZljfdb12o3iGQQ32BobRCE2JwblW2d18a4cN7uDOVpXdqV1EsqsL7KfNtoYG13oAN3i3wl3fjjeNFfTKNm0Np-jIQOX0i_15gr6uPnzJPgWX6495trwMVEhTHpQ8ZDE3UDJaJIURIjGam4gCM2VaRGUCRAimY6Y0ZcSIgnEeGUJDzcoijkV4gl7vcn2Fn1vtBllbp3RVQaPbrZNJykVCaeqN33ZG5bu6XhvZ9baG_l5SIkdCUo6E5LhuOa5b_iEk41Qy6QlJ6QnJkZAMJZHZ2j9f--CX-wbbotblIXaPxOuv9jo4j8b00CjrDjbGkyRl_G-_W1vp-3_K_bfbI9Ue5vA35YK5Hw</recordid><startdate>19961009</startdate><enddate>19961009</enddate><creator>Tremblay, Lise</creator><creator>Hauck, Wendy</creator><creator>Aprikian, Armen G.</creator><creator>Begin, Louis R.</creator><creator>Chapdelaine, Alcide</creator><creator>Chevalier, Simone</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19961009</creationdate><title>Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma</title><author>Tremblay, Lise ; Hauck, Wendy ; Aprikian, Armen G. ; Begin, Louis R. ; Chapdelaine, Alcide ; Chevalier, Simone</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3184-d43264fad21b7bf997fe4f51a2fd8b5d7a0992e62ce120f9b2445f013e2db6693</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Biological and medical sciences</topic><topic>Cell Adhesion Molecules - metabolism</topic><topic>Cytoskeletal Proteins - metabolism</topic><topic>Focal Adhesion Kinase 1</topic><topic>Focal Adhesion Protein-Tyrosine Kinases</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Neoplasm Proteins - metabolism</topic><topic>Nephrology. Urinary tract diseases</topic><topic>Paxillin</topic><topic>Phosphoproteins - metabolism</topic><topic>Phosphorylation</topic><topic>Prostatic Neoplasms - metabolism</topic><topic>Protein-Tyrosine Kinases - metabolism</topic><topic>src Homology Domains</topic><topic>src-Family Kinases - metabolism</topic><topic>Tumor Cells, Cultured</topic><topic>Tumors of the urinary system</topic><topic>Urinary tract. Prostate gland</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tremblay, Lise</creatorcontrib><creatorcontrib>Hauck, Wendy</creatorcontrib><creatorcontrib>Aprikian, Armen G.</creatorcontrib><creatorcontrib>Begin, Louis R.</creatorcontrib><creatorcontrib>Chapdelaine, Alcide</creatorcontrib><creatorcontrib>Chevalier, Simone</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tremblay, Lise</au><au>Hauck, Wendy</au><au>Aprikian, Armen G.</au><au>Begin, Louis R.</au><au>Chapdelaine, Alcide</au><au>Chevalier, Simone</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>1996-10-09</date><risdate>1996</risdate><volume>68</volume><issue>2</issue><spage>164</spage><epage>171</epage><pages>164-171</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><coden>IJCNAW</coden><abstract>Pp125FAK, a protein tyrosine kinase (PTK) co‐localized with integrins in focal adhesion plaques, is known to transduce signals involved in the regulation of cell adhesion and motility as well as the anchorage‐independent growth of transformed cells. We investigated whether pp125FAK could be part of a signalling pathway that contributes to the progression of human prostate carcinoma (PCa). Up‐regulation of pp125FAK expression, its activation by phosphorylation on tyrosine and its association with paxillin and p50csk were preferentially observed in PCa tissues from patients with metastases, whereas normal and hyperplastic prostates and localized PCa tissues showed undetectable or low levels of both FAK mRNA and protein and an absence of pp125FAK signalling complexes. The increase in expression and activation of pp125FAK in metastatic PCa tissues was also corroborated by our findings in human PCa cell lines. Indeed, higher levels of pp125FAK and FAK mRNA were observed in highly tumorigenic PC‐3 cells as was the presence of activated pp125FAK, as opposed to an inactive form in LNCaP cells, which have a lower tumorigenic ability. In addition, pp125FAK formed signalling complexes with both paxillin and p50csk in PC‐3 cells as in metastatic PCa tissues. Together, our results show that an increase in FAK mRNA and protein, as well as pp125FAK activation and association with signalling proteins, correlates with progression and invasion in human PCa tissues and cells. © 1996 Wiley‐Liss, Inc.</abstract><cop>New York</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>8900422</pmid><doi>10.1002/(SICI)1097-0215(19961009)68:2&lt;169::AID-IJC4&gt;3.0.CO;2-W</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0020-7136
ispartof International journal of cancer, 1996-10, Vol.68 (2), p.164-171
issn 0020-7136
1097-0215
language eng
recordid cdi_proquest_miscellaneous_78497118
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via Wiley Online Library
subjects Biological and medical sciences
Cell Adhesion Molecules - metabolism
Cytoskeletal Proteins - metabolism
Focal Adhesion Kinase 1
Focal Adhesion Protein-Tyrosine Kinases
Humans
Male
Medical sciences
Neoplasm Proteins - metabolism
Nephrology. Urinary tract diseases
Paxillin
Phosphoproteins - metabolism
Phosphorylation
Prostatic Neoplasms - metabolism
Protein-Tyrosine Kinases - metabolism
src Homology Domains
src-Family Kinases - metabolism
Tumor Cells, Cultured
Tumors of the urinary system
Urinary tract. Prostate gland
title Focal adhesion kinase (pp125FAK) expression, activation and association with paxillin and p50CSK in human metastatic prostate carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T23%3A27%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Focal%20adhesion%20kinase%20(pp125FAK)%20expression,%20activation%20and%20association%20with%20paxillin%20and%20p50CSK%20in%20human%20metastatic%20prostate%20carcinoma&rft.jtitle=International%20journal%20of%20cancer&rft.au=Tremblay,%20Lise&rft.date=1996-10-09&rft.volume=68&rft.issue=2&rft.spage=164&rft.epage=171&rft.pages=164-171&rft.issn=0020-7136&rft.eissn=1097-0215&rft.coden=IJCNAW&rft_id=info:doi/10.1002/(SICI)1097-0215(19961009)68:2%3C169::AID-IJC4%3E3.0.CO;2-W&rft_dat=%3Cproquest_cross%3E78497118%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78497118&rft_id=info:pmid/8900422&rfr_iscdi=true